Microbot Medical Inc. — Director's Dealing 2018

Jan 24, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2017-12-28

Reporting Person: Naim David Ben (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-28	Stock Option (Right to Buy)	$1.02	A	75000	Acquired	2027-12-28	Common Stock, par value $0.01 per share (75000)	Direct

Footnotes

F1: The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on the six month anniversary of the date of grant, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.